최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기동의생리병리학회지 = Journal of physiology & pathology in Korean Medicine, v.20 no.3, 2006년, pp.701 - 709
안진영 (세명대학교 한의과대학 내과학교실) , 고성규 (경희대학교 한의과대학 예방의학교실) , 고흥 (세명대학교 한의과대학 내과학교실)
The Rhus verniciflua Stokes (乾漆-RVS) has been used in traditional East Asia medicine for the therapy of gastritis, stomach cancer, although the mechanism for the biological activity is unclear. In the present study aims to investigate RVS extract contributes to growth inhibitory effect and it's the ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
통계청. 2004년도 사망원인통계결과, 서울. 통계청, pp 13-15, 2005
윤성우, 유봉하, 박동원, 유기원. 위암이 동의학 및 동서의 결합치료에 관한 문헌적 고찰. 대한종양학회지. 2(1):177-192, 1996
김동희, 김성훈. 抗癌劑 및 放射線 副作用에 대한 韓方療法. 동의병리학회지. 9:239-264, 1994
안덕균. 한국본초도감. 서울. 교학사, p 729, 2003
Jung, N.C. Biological activity of urushiol and flavonoids from Lac tree (Rhus verniciflua Stokes). Ph.D. Thesis, Chonnam National University, Kwang-ju, South Korea, 1998
Lee, J.C., Lim, K.T. and Jang, Y.S. Identification of Rhus verniciflua Stokes compounds that exhibit free radical scavenging and anti-apoptotic properties. Biochimica et Biophysica Acta., 1570:181-191, 2002
Kitts, D.D., and Lim, K. TAntitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes (乾漆). Journal of Toxicology and Environmental Health Part A. 64:357-371, 2001
Lee, J.C., Kim, J. and Jang, Y.S. Ethanol-eluted extract of Rhus verniciflua stokes inhibits cell growth and induces apoptosis in human lymphoma cells. J Biochem Mol Biol.. 4:337-343, 2003
Lee, J.C., Lee, K.Y., Kim, J.N., et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol. 9:1383-1388, 2004
Meier, P., Finch, A. and Evan, G. Apoptosis in development. Nature. 407:796-801, 2000
Jonstone, R.W. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 108:153-164, 2002
Green, D.R. Apoptotic pathways: paper wraps stone blunts scissors. Cell. 102:1-4, 2000
Kothakota, S., Azuma, T., Reinhard, C. et al. Caspase- 3-generated fragment of gelsolin: Effector of morphological change in apoptosis. Science. 278:294-298, 1997
Nunez, G., Benedict, M.A., Hu, Y. and Inohara, N. Caspases: The proteases of the apoptotic pathway. Oncogene. 17:3237-3245, 1998
Adams, J.M. and Cory, S. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322-1326, 1998
Atan, G., James, M.M. and Stanley, J.K. Bcl-2 family members and the mitochondria in apoptosis. Genes. Dev. 13:1899-1911, 1999
Nasmyth, K. Viewpoint: putting the cell cycle in order. Science. 274:1643-1645, 1996
Sherr, C.J. and Roberts, J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev.. 12:1501-1121, 1999.
Polyak, K., Kato, J.Y., Solomon, M.J., Sherr, C.J., Massague, J., Roberts, J.M., and Koff, A. P27 KIP1, a cyclin Cdk inhibitor, links transforming growth factor beta and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22, 1994
Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.Cell. 78:67-74, 1994
Coats, S., Flanagen, M., Nourse, J., and Roberts, J.M. Requirement of p27kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877-880, 1996
Coqueret, O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment Trends. Cell Biol. 2:65-70, 2003
Elledge, S.J. and Harper, J.W. The role of protein stability in the cell cycle and cancer. Biochim. Biophys. Acta. 1377:M61-M70, 1998
Pagano, M., Tam, S.W., Theodoras, A.M. et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Wash. DC). 269:682-685, 1995
Schulman, B.A., Carrano, A.C., Jeffrey, P.D. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature (Lond.). 408:381-386, 2000
Carrano, A.C., Eytan, E., Hershko, A. and Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:193-199, 1999.
Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Muller, U. and Krek, W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:207-214, 1999
Tsvetkov, L.M., Yeh, K.H., Lee, S.J., Sun, H. and Zhang, H. p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9:661-664, 1999
Nakayama, K.I., Hatakeyama, S. and Nakayama, K. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun. 4:853-860, 2001
Masuda, T.A., Inoue, H., Sonoda, H. et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 13:3819-3825, 2002
Nevins, J.R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science. 258:424-429, 1992
Flemington, E.K., Speck, S.H., and Kaelin, Jr. W.G. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA, 90:6914-6918, 1993
Helin, K., Harlow, E. and Fattaey, A.R. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508, 1993
Humbert, P.O., Verona, R., Trimarchi, J.M., Rogers, C., Dandapani, S. and Lees, J.A. E2F3 is critical for normal cellular proliferation. Genes Dev. 14:690-703, 2000
Dalton, S. Cell cycle regulation of the human cdc2 gene. EMBO J. 11:1797-1804, 1992
Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M. and Clurman, B.E. Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev.. 11:1464-1478, 1997
Vlach, J., Hennecke, S., and Amati, B. Phosphorylation- dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J., 16:5334-5344, 1997
Lloyd, R.V., Erickson, L.A., Jin, L. et al. p27kip1: a multifunctional cyclin dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol., 2:313-323, 1999
Stacy, W.B. p27 as a target for cancer therapeutics. Cancer cell. 3:111-115, 2003
Masuda, T.A., Inoue, H., Sonoda, H. et al. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res. 13:3819-3825, 2002
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.